0000000000120052

AUTHOR

Marina Vaglica

Weekly docetaxel (wDOC) for the treatment of metastatic breast cancer (MBC): A literature based meta-analysis

research product

“Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with metastatic (M) breast cancer (BC): results of an observational study”

research product

“Serum HER-2/neu (s-HER2) levels evaluation in breast cancer (BC) patients (PTS)”

research product

“Final results of a phase II trial of a weekly (W) poly-chemotherapy (CT) with cisplatin (CDDP), epirubicin (EPI), fluorouracil (5FU), folinic acid (FA) and G-CSF for the treatment of gastroesophageal (GE) and gastric (G) cancer (C)”

research product

"Evaluating the prognostic role of serum extracellular domain (ECD) of HER-2/neu (s-HER2) in patients (PTS) with early (E) breast cancer (BC)”

research product

“Analysis of serum HER-2/neu levels (S-HER2) in breast cancer (BC) patients (pts)”

research product